(1 - 25 from 38
)
'Inflexible' NICE blocking access to rare disease drugs - PMLiVE
www.pmlive.com
Feb 19, — Genetic Alliance CEO Jayne Spink ... systems for access to rare disease treatments,” Jayne Spink PhD, chief executive, Genetic Alliance UK. › pharma_news › inflexible_ni...
2018 IQVIA BIOTECH SUMMIT | BIA - BioIndustry Association
www.bioindustry.org
Jun 26, — Jayne Spink, Chief Executive, Genetic Alliance UK, Chair of Rare Diseases UK; Georg Toufar, CEO, Kronberg Associates (Grow. Build. Turn Around) ... › sector-event-listing ›
Brexit Could Have Real Effects for UK Rare Disease Patients ...
fabrydiseasenews.com
Mar 15, — Jayne Spink, chief executive of Genetic Alliance UK, said the EU has provided Britain's rare disease patients with invaluable provisions, ... › news › brexit-could-hav...
Calls for Revolutionary Genomic Medicine to Benefit VWV
www.vwv.co.uk
Jan 17, — Dr Jayne Spink, Chief Executive Officer of the Genetic Alliance UK, spoke at the event about a paper that her organisation is going to ... › blog › pharma-life-sciences-law
sorted by relevance / date